Table 5 Session product characteristics’ effects on symptom relief when using inhaled, dried Cannabis flower and treating cannabinoid measurements as categorical variables
| Â | Overall sample | Agitation/irritability | Anxiety | Stress |
|---|---|---|---|---|
(1) | (2) | (3) | (4) | |
THC 10–19%/dry wt. | − 0.377** (0.123) | − 0.472 (0.469) | − 0.618*** (0.170) | − 0.024 (0.167) |
THC 20–30%/dry wt. | − 0.345** (0.117) | − 0.131 (0.452) | − 0.599*** (0.165) | 0.214 (0.162) |
CBD 1–9%/dry wt. | 0.007 (0.138) | − 0.333 (0.217) | 0.120 (0.152) | 0.518 (0.411) |
CBD 10–30%/dry wt. | − 0.057 (0.188) | − 0.270 (0.292) | − 0.051 (0.199) | 0.530 (0.409) |
C. indica | − 0.024 (0.106) | − 0.163 (0.200) | 0.037 (0.141) | − 0.110 (0.174) |
C. sativa | 0.212* (0.104) | 0.068 (0.243) | 0.231 (0.131) | − 0.227 (0.171) |
Pipe | 0.079 (0.260) | 0.418 (0.646) | − 0.41 (0.220) | 0.116 (0.265) |
Vape | 0.146 (0.274) | 0.634 (0.672) | − 0.229 (0.257) | 0.089 (0.313) |
Session length (min) | − 0.007*** (0.001) | − 0.005* (0.002) | − 0.007*** (0.001) | − 0.008*** (0.001) |
Baseline symptom intensity | − 0.661*** (0.039) | − 0.693*** (0.072) | − 0.604*** (0.067) | − 0.667*** (0.052) |
Constant | 0.219 (0.300) | − 0.105 (0.848) | 0.649 (0.350) | − 0.402 (0.478) |
Number of sessions | 2306 | 422 | 998 | 886 |
Number of users | 670 | 206 | 441 | 360 |